Also, increased galectin-3 levels have been associated with all-cause mortality in T2DM patients with low [34] and high [35] cardiovascular risk, even without prior CVD and independently of traditional risk factors. This evidence concerns the gene LGALS3 and type 2 diabetes mellitus.